An updated systematic review and meta-analysis of Caplacizumab for immune thrombotic thrombocytopenic purpura: Insights into efficacy and safety
<p>This review synthesizes the current evidence to assess the efficacy and safety of caplacizumab in the treatment of iTTP, focusing on its impact on TPE requirements, time to platelet normalization, relapse prevention, and treatment-related adverse events. Thirteen studies (11 observational a...
محفوظ في:
| المؤلف الرئيسي: | Mohamed Yassin (4166515) (author) |
|---|---|
| مؤلفون آخرون: | Rola Ghasoub (16555851) (author), Neda Jafari (22963048) (author), Lulwah Al-Tourah (22963051) (author), Anas Babiker (22963054) (author), Muna AlRasheed (22963057) (author) |
| منشور في: |
2025
|
| الموضوعات: | |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|
مواد مشابهة
-
Caplacizumab for pediatric immune thrombotic thrombocytopenic Purpura: A scoping review of current evidence
حسب: Abdulrahman F. Al-Mashdali (17148316)
منشور في: (2025) -
Thrombotic and Hypercoagulability Complications of COVID-19: An Update
حسب: Sapha Shibeeb (7903268)
منشور في: (2021) -
Acrocyanosis and necrotic purpura
حسب: Nasser, Selim
منشور في: (2015) -
Protein prenylation restrains innate immunity by inhibiting Rac1 effector interactions
حسب: Murali K. Akula (9389280)
منشور في: (2019) -
Plasma exchange (PE) versus intravenous immunoglobulin (IVIG) for the treatment of Guillain-Barré syndrome (GBS) in patients with severe symptoms: A systematic review and meta-analysis
حسب: Hany A. Zaki (15954222)
منشور في: (2023)